Sustained transgenic overexpression of IL-1ß was shown to have a beneficial effect on amyloid burden without overt neurodegeneration in the APP/PS1 and APPswe/PS-1dE9 mouse models of Aβ-associated neuropathy (62, 63). This evidence concerns the gene APP and neuropathy.